Logo image of STML

Stemline Therapeutic (STML) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:STML -

11.83
-0.17 (-1.42%)
Last: 6/9/2020, 8:17:17 PM
11.83
0 (0%)
After Hours: 6/9/2020, 8:17:17 PM
Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to STML. The Buy consensus is the weighted average rating of the current analysts ratings.

  • STML was analyzed by 7 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about STML.
  • In the previous month the buy percentage consensus was at a similar level.
  • STML was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

STML Historical Analyst RatingsSTML Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8
STML Current Analyst RatingSTML Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Stemline Therapeutic / STML FAQ

What is the consensus rating for Stemline Therapeutic (STML) stock?

The consensus rating for Stemline Therapeutic (STML) is 77.2 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts cover Stemline Therapeutic (STML) stock?

The number of analysts covering Stemline Therapeutic (STML) is 7.